chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash at left axilla; rash on the right arm; This spontaneous case was reported by a health care professional and describes the occurrence of RASH (rash on the right arm) and RASH (rash at left axilla) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ACETYLCYSTEINE (NAC [ACETYLCYSTEINE]) from 04-Oct-2018 to an unknown date, HOLY BASIL from 04-Oct-2018 to an unknown date, VITAMIN D [VITAMIN D NOS] from 04-Oct-2018 to an unknown date and ZINC from 04-Oct-2018 to an unknown date for Supplementation therapy.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced RASH (rash on the right arm). On 14-Mar-2021 at 10:00 AM, the patient experienced RASH (rash at left axilla). At the time of the report, RASH (rash on the right arm) and RASH (rash at left axilla) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   treatment to the events not provided. After 2nd injection 8-10 later the exact same type of rash showed up in the left armpit. It is still red and not totally resolved. I do not take any medications and am in very good shape. I have not changed any of my soap, laundry detergent or deodorants nor anything else that may have caused this.   This case was linked to US-MODERNATX, INC.-MOD-2021-059767 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: follow up information received, Patient demographic details,  events , outcome of the event updated, concomitant medications added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-059767:Crosslinked case
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Rash, Rash pruritic
Clinical narrative: Itchy rash at the forearm; Red rash at the forearm; hip pain; Low back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Low back pain), RASH PRURITIC (Itchy rash at the forearm), RASH (Red rash at the forearm) and ARTHRALGIA (hip pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced BACK PAIN (Low back pain) and ARTHRALGIA (hip pain). On 26-Mar-2021, the patient experienced RASH PRURITIC (Itchy rash at the forearm) and RASH (Red rash at the forearm). At the time of the report, BACK PAIN (Low back pain) had not resolved and RASH PRURITIC (Itchy rash at the forearm), RASH (Red rash at the forearm) and ARTHRALGIA (hip pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was reported.  Treatment included using heating pad for low back pain.   This case was linked to MOD-2021-062559 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, SARS-CoV-2 test: (Positive) Patient stated that after receiving her first dose, she was tested positive for COVID-19..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication information was reported. Patient stated that on 19-Mar-2021, she tested positive for COVID-19 though she did not show any symptoms and wanted to know whether she could receive the second dose.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Ephelides, Fatigue, Pain in extremity, Rash
Clinical narrative: Weird rash; Really Small freckles; Soreness of the arm; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of the arm), FATIGUE (Tired), RASH (Weird rash) and EPHELIDES (Really Small freckles) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided by reporter.  Concomitant products included AMITRIPTYLINE, GLICLAZIDE (DYAZIDE [GLICLAZIDE]), LEVOTHYROXINE SODIUM (SYNTHROID) and FLUTICASONE for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness of the arm) and FATIGUE (Tired). On 29-Mar-2021, the patient experienced RASH (Weird rash) and EPHELIDES (Really Small freckles). At the time of the report, PAIN IN EXTREMITY (Soreness of the arm), FATIGUE (Tired), RASH (Weird rash) and EPHELIDES (Really Small freckles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment included Patient is diagnosed for Mast cell Disorder and is under medication
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on arm and elbow; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on arm and elbow) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     Concomitant products included TRAZODONE, CITALOPRAM, METOPROLOL and PRAVASTATIN for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced RASH (Rash on arm and elbow). At the time of the report, RASH (Rash on arm and elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication information was reported. Reporter stated that the patient has a history of right side stroke including the right hand. Hence the vaccine was administered on his right arm that way he could still use the left hand which was not affected by the stroke.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient did not receive second dose in allowed time window; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient did not receive second dose in allowed time window) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient did not receive second dose in allowed time window). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient did not receive second dose in allowed time window) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant medications are provided. treatment to the events not reported.  After her specific reaction to the first dose of the vaccine, the patient decided to forgo the second dose of the Moderna COVID-19 vaccine. She is now out of the allowed time window and is not planning on receiving at any point
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: missed his second dose; tested positive for COVID19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID19) and PRODUCT DOSE OMISSION ISSUE (missed his second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID19). On 11-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed his second dose). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for COVID19) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (missed his second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Feb-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications are provided. treatment to the events not reported.  On 22Feb2021, he had symptoms of COVID19 (fever, chills, cold-like symptoms) and tested positive for COVID19. He missed his second dose which was scheduled on 11March2021.
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Lip swelling, Urticaria
Clinical narrative: Hives; lips really swollen; woke up with an allergic reaction; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (Hives), LIP SWELLING (lips really swollen) and ALLERGY TO VACCINE (woke up with an allergic reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced URTICARIA (Hives), LIP SWELLING (lips really swollen) and ALLERGY TO VACCINE (woke up with an allergic reaction). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. On 27-Mar-2021, URTICARIA (Hives) had resolved. On 29-Mar-2021, LIP SWELLING (lips really swollen) had resolved. At the time of the report, ALLERGY TO VACCINE (woke up with an allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not provided.  Treatment for the event included Benadryl & steroids.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling of eyelid
Clinical narrative: Swollen eyelids; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING OF EYELID (Swollen eyelids) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 29-Mar-2021, the patient experienced SWELLING OF EYELID (Swollen eyelids). The patient was treated with CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) ongoing since an unknown date at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, SWELLING OF EYELID (Swollen eyelids) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant Text: The patient received the first dose of the Moderna COVID-19 vaccine on 26 Mar 2021 and on 29 Mar 2021 the patient woke up with swollen eyelids, especially the one from the side of the vaccination. The swelling subsided on the same day but on 30 Mar 2021 morning, the eyelids were swollen again.   No Concomitant product use was reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: left hand tingling like pins and needles; Numbness in hands (left); numbness on left side of the face; This spontaneous case was reported by a consumer and describes the occurrence of   in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Dental treatment NOS.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Chills, Musculoskeletal chest pain, Myalgia, Pyrexia
Clinical narrative: Ribs hurt(not sure if lungs or muscles); Lost my voice; I've had all those" when agent shared common side effects; chills; body aches; Throwing Up; Fever of 102F; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (Ribs hurt), VACCINATION COMPLICATION (I've had all those" when agent shared common side effects), APHONIA (Lost my voice), CHILLS (chills) and PYREXIA (Fever of 102F) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No significant historical event reported.).    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 25-Mar-2021, the patient experienced PYREXIA (Fever of 102F). On 29-Mar-2021, the patient experienced VOMITING (Throwing Up). On an unknown date, the patient experienced MUSCULOSKELETAL CHEST PAIN (Ribs hurt), VACCINATION COMPLICATION (I've had all those" when agent shared common side effects), APHONIA (Lost my voice), CHILLS (chills) and MYALGIA (body aches). At the time of the report, MUSCULOSKELETAL CHEST PAIN (Ribs hurt), VACCINATION COMPLICATION (I've had all those" when agent shared common side effects), APHONIA (Lost my voice), CHILLS (chills), MYALGIA (body aches) and VOMITING (Throwing Up) outcome was unknown and PYREXIA (Fever of 102F) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vomiting
Clinical narrative: Ribs hurt(not sure if lungs or muscles); Lost my voice; I've had all those" when agent shared common side effects; chills; body aches; Throwing Up; Fever of 102F; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (Ribs hurt), VACCINATION COMPLICATION (I've had all those" when agent shared common side effects), APHONIA (Lost my voice), CHILLS (chills) and PYREXIA (Fever of 102F) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No significant historical event reported.).    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 25-Mar-2021, the patient experienced PYREXIA (Fever of 102F). On 29-Mar-2021, the patient experienced VOMITING (Throwing Up). On an unknown date, the patient experienced MUSCULOSKELETAL CHEST PAIN (Ribs hurt), VACCINATION COMPLICATION (I've had all those" when agent shared common side effects), APHONIA (Lost my voice), CHILLS (chills) and MYALGIA (body aches). At the time of the report, MUSCULOSKELETAL CHEST PAIN (Ribs hurt), VACCINATION COMPLICATION (I've had all those" when agent shared common side effects), APHONIA (Lost my voice), CHILLS (chills), MYALGIA (body aches) and VOMITING (Throwing Up) outcome was unknown and PYREXIA (Fever of 102F) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Pain in extremity, Underdose
Clinical narrative: left arm is sore; invalid dose; felt fluid drip down the outside of his arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (left arm is sore), UNDERDOSE (invalid dose) and DEVICE CONNECTION ISSUE (felt fluid drip down the outside of his arm) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced UNDERDOSE (invalid dose) and DEVICE CONNECTION ISSUE (felt fluid drip down the outside of his arm). On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (left arm is sore). On 29-Mar-2021, UNDERDOSE (invalid dose) and DEVICE CONNECTION ISSUE (felt fluid drip down the outside of his arm) had resolved. At the time of the report, PAIN IN EXTREMITY (left arm is sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Pain in extremity, Pyrexia
Clinical narrative: Loose stools; Arm was hurting; vomiting; headache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Loose stools), PAIN IN EXTREMITY (Arm was hurting), VOMITING (vomiting), HEADACHE (headache) and CHILLS (chills) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Thyroid disorder. Concomitant products included VORTIOXETINE HYDROBROMIDE (TRINTELLIX) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced DIARRHOEA (Loose stools), PAIN IN EXTREMITY (Arm was hurting), VOMITING (vomiting), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). On 29-Mar-2021, DIARRHOEA (Loose stools), PAIN IN EXTREMITY (Arm was hurting), VOMITING (vomiting), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Loose stools; Arm was hurting; vomiting; headache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Loose stools), PAIN IN EXTREMITY (Arm was hurting), VOMITING (vomiting), HEADACHE (headache) and CHILLS (chills) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Thyroid disorder. Concomitant products included VORTIOXETINE HYDROBROMIDE (TRINTELLIX) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced DIARRHOEA (Loose stools), PAIN IN EXTREMITY (Arm was hurting), VOMITING (vomiting), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). On 29-Mar-2021, DIARRHOEA (Loose stools), PAIN IN EXTREMITY (Arm was hurting), VOMITING (vomiting), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash, Swelling face
Clinical narrative: Rash on her face got really bad; Whole face swelling; Redness on her whole face after the second dose; Itching on her whole face after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Whole face swelling), ERYTHEMA (Redness on her whole face after the second dose), PRURITUS (Itching on her whole face after the second dose) and RASH (Rash on her face got really bad) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to Benadryl).   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced SWELLING FACE (Whole face swelling), ERYTHEMA (Redness on her whole face after the second dose) and PRURITUS (Itching on her whole face after the second dose). On 20-Mar-2021, the patient experienced RASH (Rash on her face got really bad). At the time of the report, SWELLING FACE (Whole face swelling), ERYTHEMA (Redness on her whole face after the second dose), PRURITUS (Itching on her whole face after the second dose) and RASH (Rash on her face got really bad) outcome was unknown.            This case was linked to MOD-2021-056203 (Patient Link).
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Dysstasia, Fatigue, Headache
Clinical narrative: shortness of breath; couldn't stand up; felt really weak; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), DYSSTASIA (couldn't stand up), ASTHENIA (felt really weak), HEADACHE (headache) and FATIGUE (fatigue) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder. Concomitant products included METHOTREXATE for Autoimmune disorder, APIXABAN (ELIQUIS), DRONEDARONE HYDROCHLORIDE (MULTAQ), HYDROCHLOROTHIAZIDE, ATENOLOL, AMLODIPINE BESILATE (NORVASC), FLUCONAZOLE (DIFLUCAN) and ESTROGENS CONJUGATED (PREMARIN) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced DYSPNOEA (shortness of breath), DYSSTASIA (couldn't stand up), ASTHENIA (felt really weak), HEADACHE (headache) and FATIGUE (fatigue). On 12-Mar-2021, DYSPNOEA (shortness of breath), DYSSTASIA (couldn't stand up), ASTHENIA (felt really weak), HEADACHE (headache) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Other concomitant medication included potassium, betamethasone, eylea(aflibercept) for macular degeneration.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: chills; tiredness; Fever of 102; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), FATIGUE (tiredness) and PYREXIA (Fever of 102) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 003A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included HYDROCHLOROTHIAZIDE, APIXABAN (ELIQUIS), ESCITALOPRAM OXALATE (LEXAPRO) and LISINOPRIL for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced CHILLS (chills), FATIGUE (tiredness) and PYREXIA (Fever of 102). On 18-Feb-2021, CHILLS (chills), FATIGUE (tiredness) and PYREXIA (Fever of 102) had resolved. Not Provided
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered a dose to a patient from a vial that had already been punctured for 8 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered a dose to a patient from a vial that had already been punctured for 8 hours). On 30-Mar-2021, EXPIRED PRODUCT ADMINISTERED had resolved. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided. Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 037A21B) with no associated AEs.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: mild headache; chills; fatigue; fever of 100.4 F; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (mild headache), CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever of 100.4 F) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006A21A) for COVID-19 immunisation.     No Medical History information was reported.   On 29-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced HEADACHE (mild headache), CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever of 100.4 F). At the time of the report, HEADACHE (mild headache), CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever of 100.4 F) had not resolved. Not Provided          Concomitant medication information not provided.  Treatment information not provided.  Action taken with mRNA-1273 in response to the event/s was not applicable
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain, Vaccination site warmth
Clinical narrative: Warm to touch at site of injection; Rash on the upper arm, just above the injection site; Burning at site of injection; Stinging at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch at site of injection), RASH (Rash on the upper arm, just above the injection site), VACCINATION SITE PAIN (Burning at site of injection) and VACCINATION SITE PAIN (Stinging at site of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch at site of injection), RASH (Rash on the upper arm, just above the injection site), VACCINATION SITE PAIN (Burning at site of injection) and VACCINATION SITE PAIN (Stinging at site of injection). At the time of the report, VACCINATION SITE WARMTH (Warm to touch at site of injection), RASH (Rash on the upper arm, just above the injection site), VACCINATION SITE PAIN (Burning at site of injection) and VACCINATION SITE PAIN (Stinging at site of injection) outcome was unknown.            Concomitant medications were not reported. Treatment information included coldpack. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Rhinorrhoea, Sinus disorder
Clinical narrative: sinus symptoms; runny nose; stuffy nose; This spontaneous case was reported by a consumer and describes the occurrence of SINUS DISORDER (sinus symptoms), RHINORRHOEA (runny nose) and NASAL CONGESTION (stuffy nose) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 612A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SINUS DISORDER (sinus symptoms), RHINORRHOEA (runny nose) and NASAL CONGESTION (stuffy nose). At the time of the report, SINUS DISORDER (sinus symptoms), RHINORRHOEA (runny nose) and NASAL CONGESTION (stuffy nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications included OTC allergy medications. No concomitant medications were reported.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure via skin contact, Incorrect dose administered
Clinical narrative: Caller feels she didnt get a full second dose; Caller feels she didnt get a full second dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA SKIN CONTACT (Caller feels she didnt get a full second dose) and INCORRECT DOSE ADMINISTERED (Caller feels she didnt get a full second dose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced EXPOSURE VIA SKIN CONTACT (Caller feels she didnt get a full second dose) and INCORRECT DOSE ADMINISTERED (Caller feels she didnt get a full second dose). On 11-Mar-2021, EXPOSURE VIA SKIN CONTACT (Caller feels she didnt get a full second dose) and INCORRECT DOSE ADMINISTERED (Caller feels she didnt get a full second dose) had resolved. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided. No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient coming in for second dose at 60 days; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient coming in for second dose at 60 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient coming in for second dose at 60 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient coming in for second dose at 60 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Nasal congestion
Clinical narrative: nasal congestion; Feeling abnormal; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nasal congestion) and FEELING ABNORMAL (Feeling abnormal) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced FEELING ABNORMAL (Feeling abnormal). On 05-Jan-2021, the patient experienced NASAL CONGESTION (nasal congestion). On 04-Jan-2021, FEELING ABNORMAL (Feeling abnormal) had resolved. On 19-Jan-2021, NASAL CONGESTION (nasal congestion) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-062598 (E2B Linked Report). This case was linked to MOD-2021-062598 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-062598:
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity, Vaccination site pain
Clinical narrative: Pain the arm; Pain in hip an knees; Pain in the left side/Pain stronger in the injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain the arm), ARTHRALGIA (Pain in hip an knees) and VACCINATION SITE PAIN (Pain in the left side/Pain stronger in the injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Medical History Reported).    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain the arm), ARTHRALGIA (Pain in hip an knees) and VACCINATION SITE PAIN (Pain in the left side/Pain stronger in the injection). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain the arm) had not resolved and ARTHRALGIA (Pain in hip an knees) and VACCINATION SITE PAIN (Pain in the left side/Pain stronger in the injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: lots of headache; Had a bit of nausea too; headache is a bit strong; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (lots of headache), NAUSEA (Had a bit of nausea too) and HEADACHE (headache is a bit strong) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (lots of headache), NAUSEA (Had a bit of nausea too) and HEADACHE (headache is a bit strong). At the time of the report, HEADACHE (lots of headache), NAUSEA (Had a bit of nausea too) and HEADACHE (headache is a bit strong) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant included no treatment included
Sex: U
Vaccine: COVID19
Symptoms: Skin reaction
Clinical narrative: Severe skin reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SKIN REACTION (Severe skin reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN REACTION (Severe skin reaction). At the time of the report, SKIN REACTION (Severe skin reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Tachycardia
Clinical narrative: Tachycardia for 15 minutes; PA states she's due for the second dose this Friday, 2Apr2021; This spontaneous case was reported by an other health care professional and describes the occurrence of TACHYCARDIA (Tachycardia for 15 minutes) and PRODUCT DOSE OMISSION ISSUE (PA states she's due for the second dose this Friday, 2Apr2021) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Thyroid disorder (PA also informed us as FYI that patient has thyroid problems.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TACHYCARDIA (Tachycardia for 15 minutes) and PRODUCT DOSE OMISSION ISSUE (PA states she's due for the second dose this Friday, 2Apr2021). At the time of the report, TACHYCARDIA (Tachycardia for 15 minutes) and PRODUCT DOSE OMISSION ISSUE (PA states she's due for the second dose this Friday, 2Apr2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient has valves issues and they came back for Lab work and EKG.  No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow up information received contains significant information. Added Events, Added Medical history.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; One of my nurses gave a dose to a patient 6 hrs and 36 minutes post vial puncture; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (One of my nurses gave a dose to a patient 6 hrs and 36 minutes post vial puncture) and NO ADVERSE EVENT (No adverse event) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included Pancreatic cancer and COPD. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), BUSPIRONE, CLONIDINE, APIXABAN (ELIQUIS), FLUTICASONE and ALPRAZOLAM for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (One of my nurses gave a dose to a patient 6 hrs and 36 minutes post vial puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). On 25-Mar-2021, EXPIRED PRODUCT ADMINISTERED (One of my nurses gave a dose to a patient 6 hrs and 36 minutes post vial puncture) had resolved. At the time of the report, NO ADVERSE EVENT (No adverse event) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow up received on 04-jun-2021 contains non significant information.; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 006B21A)  with no associated AEs.
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Rash, Vaccination site rash
Clinical narrative: Rash that started around the injection area; Rash that spread to other parts of his body; redness on both his hands; rash on both his hands; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash that started around the injection area), RASH (Rash that spread to other parts of his body), ERYTHEMA (redness on both his hands) and RASH (rash on both his hands) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash that started around the injection area), RASH (Rash that spread to other parts of his body), ERYTHEMA (redness on both his hands) and RASH (rash on both his hands). At the time of the report, VACCINATION SITE RASH (Rash that started around the injection area), RASH (Rash that spread to other parts of his body), ERYTHEMA (redness on both his hands) and RASH (rash on both his hands) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-066021 (E2B Linked Report).; Sender's Comments:  MOD21-066021:crosslinked to patient case
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Pain in extremity
Clinical narrative: Feeling of fireworks in entire body that went away and reappear two days ago in her extremities; Painful in extremities; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Feeling of fireworks in entire body that went away and reappear two days ago in her extremities) and PAIN IN EXTREMITY (Painful in extremities) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 immunisation.     Concurrent medical conditions included Lupus syndrome, Scleroderma and Neuropathy.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (Feeling of fireworks in entire body that went away and reappear two days ago in her extremities) and PAIN IN EXTREMITY (Painful in extremities). At the time of the report, BURNING SENSATION (Feeling of fireworks in entire body that went away and reappear two days ago in her extremities) and PAIN IN EXTREMITY (Painful in extremities) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications reported include medications for autoimmune disease: lupus, scleroderma and neuropathy.  No treatment information was provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Feeling hot, Headache
Clinical narrative: Total body aches; Feeling hot; Achy; Has not been good; fever of 100.7; chills; Headache; joint aches; This spontaneous case was reported by an other caregiver and describes the occurrence of PAIN (Total body aches), FEELING HOT (Feeling hot), PAIN (Achy), MALAISE (Has not been good) and PYREXIA (fever of 100.7) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy. Concomitant products included DOXYCYCLINE for Skin infection, FAMOTIDINE (PEPCID AC) for Sour stomach.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced PAIN (Total body aches), FEELING HOT (Feeling hot), PAIN (Achy), MALAISE (Has not been good), PYREXIA (fever of 100.7), CHILLS (chills), HEADACHE (Headache) and ARTHRALGIA (joint aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Total body aches), FEELING HOT (Feeling hot), PAIN (Achy), MALAISE (Has not been good), PYREXIA (fever of 100.7), CHILLS (chills), HEADACHE (Headache) and ARTHRALGIA (joint aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Mar-2021, Body temperature: 100.7 High.         Patient was able to drink fluids as treatment.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Pain, Pyrexia
Clinical narrative: Total body aches; Feeling hot; Achy; Has not been good; fever of 100.7; chills; Headache; joint aches; This spontaneous case was reported by an other caregiver and describes the occurrence of PAIN (Total body aches), FEELING HOT (Feeling hot), PAIN (Achy), MALAISE (Has not been good) and PYREXIA (fever of 100.7) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy. Concomitant products included DOXYCYCLINE for Skin infection, FAMOTIDINE (PEPCID AC) for Sour stomach.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced PAIN (Total body aches), FEELING HOT (Feeling hot), PAIN (Achy), MALAISE (Has not been good), PYREXIA (fever of 100.7), CHILLS (chills), HEADACHE (Headache) and ARTHRALGIA (joint aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Total body aches), FEELING HOT (Feeling hot), PAIN (Achy), MALAISE (Has not been good), PYREXIA (fever of 100.7), CHILLS (chills), HEADACHE (Headache) and ARTHRALGIA (joint aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Mar-2021, Body temperature: 100.7 High.         Patient was able to drink fluids as treatment.